<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Calibri Light";
panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
{font-family:"Nunito Sans";}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:JA;}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
margin-top:12.0pt;
margin-right:0in;
margin-bottom:0in;
margin-left:0in;
page-break-after:avoid;
font-size:16.0pt;
font-family:"Calibri Light",sans-serif;
color:#2F5496;
mso-fareast-language:JA;
font-weight:normal;}
h2
{mso-style-priority:9;
mso-style-link:"Heading 2 Char";
margin-top:2.0pt;
margin-right:0in;
margin-bottom:0in;
margin-left:0in;
page-break-after:avoid;
font-size:13.0pt;
font-family:"Calibri Light",sans-serif;
color:#2F5496;
mso-fareast-language:JA;
font-weight:normal;}
h3
{mso-style-priority:9;
mso-style-link:"Heading 3 Char";
margin-top:2.0pt;
margin-right:0in;
margin-bottom:0in;
margin-left:0in;
page-break-after:avoid;
font-size:12.0pt;
font-family:"Calibri Light",sans-serif;
color:#1F3763;
mso-fareast-language:JA;
font-weight:normal;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:8.0pt;
margin-left:.5in;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:8.0pt;
margin-left:.5in;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.Heading2Char
{mso-style-name:"Heading 2 Char";
mso-style-priority:9;
mso-style-link:"Heading 2";
font-family:"Calibri Light",sans-serif;
color:#2F5496;
mso-fareast-language:JA;}
span.Heading3Char
{mso-style-name:"Heading 3 Char";
mso-style-priority:9;
mso-style-link:"Heading 3";
font-family:"Calibri Light",sans-serif;
color:#1F3763;
mso-fareast-language:JA;}
span.EmailStyle25
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Calibri Light",sans-serif;
color:#2F5496;
mso-fareast-language:JA;}
p.xmsonormal, li.xmsonormal, div.xmsonormal
{mso-style-name:x_msonormal;
margin:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:308288672;
mso-list-template-ids:-713251720;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1
{mso-list-id:406997126;
mso-list-type:hybrid;
mso-list-template-ids:1694034546 -696608396 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l1:level1
{mso-level-start-at:0;
mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:.75in;
text-indent:-.25in;
font-family:Symbol;
mso-fareast-font-family:Calibri;
mso-bidi-font-family:Calibri;}
@list l1:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:1.25in;
text-indent:-.25in;
font-family:"Courier New";}
@list l1:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:1.75in;
text-indent:-.25in;
font-family:Wingdings;}
@list l1:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:2.25in;
text-indent:-.25in;
font-family:Symbol;}
@list l1:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:2.75in;
text-indent:-.25in;
font-family:"Courier New";}
@list l1:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:3.25in;
text-indent:-.25in;
font-family:Wingdings;}
@list l1:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:3.75in;
text-indent:-.25in;
font-family:Symbol;}
@list l1:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:4.25in;
text-indent:-.25in;
font-family:"Courier New";}
@list l1:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:4.75in;
text-indent:-.25in;
font-family:Wingdings;}
@list l2
{mso-list-id:942227415;
mso-list-type:hybrid;
mso-list-template-ids:-1830883186 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l2:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l2:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l2:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l2:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l2:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l2:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l2:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l2:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l2:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l3
{mso-list-id:1341732693;
mso-list-template-ids:173855622;}
@list l3:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l3:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l3:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3:level4
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3:level5
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3:level7
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3:level8
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l4
{mso-list-id:1534155262;
mso-list-template-ids:1885136982;}
@list l4:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l4:level2
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l4:level3
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l4:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l4:level5
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l4:level6
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l4:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l4:level8
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l4:level9
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l5
{mso-list-id:1741631666;
mso-list-type:hybrid;
mso-list-template-ids:-1009883992 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l5:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l5:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l5:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l5:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l5:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l5:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l5:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l5:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l5:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l6
{mso-list-id:2118139856;
mso-list-template-ids:-1942057160;}
@list l6:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l6:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l6:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l6:level4
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l6:level5
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l6:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l6:level7
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l6:level8
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l6:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l4:level2 lfo3
{mso-level-number-format:arabic;
mso-level-numbering:continue;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1028" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal" align="center" style="text-align:center"><b><span style="font-size:12.0pt;font-family:"Times New Roman",serif;color:#C00000">~~ Please disseminate this information with those researchers and research administrators in your department who
may find it noteworthy ~~<o:p></o:p></span></b></p>
<h1 style="mso-margin-top-alt:0in;margin-right:0in;margin-bottom:11.25pt;margin-left:0in">
<strong><span style="font-size:15.0pt;font-family:"Arial",sans-serif;font-weight:normal"><o:p> </o:p></span></strong></h1>
<p class="MsoNormal"><b><u><span style="font-size:12.0pt;color:#20558A">NIH - EXTENDING EXISTING GUIDANCE FOR PREPARING APPLICATIONS DURING COVID-19 (NIH Extramural Nexus)<o:p></o:p></span></u></b></p>
<p class="MsoNormal"><b><u><span style="font-size:12.0pt;color:#20558A"><o:p><span style="text-decoration:none"> </span></o:p></span></u></b></p>
<p class="MsoNormal">For Spring 2022 due dates, NIH recently <a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-046.html"><b>extended the guidance</b></a> that while grant applications should not include contingency or recovery plans for problems
resulting from the COVID-19 pandemic, investigators may address effects due to the pandemic on productivity or other scoreable issues in the personal statement of the biosketch. Reviewers will be instructed to take these pandemic-related circumstances into
account when assessing applicants’ productivity and other score-driving factors. If needed, NIH staff will request and assess plans to resolve specific problems arising from the COVID-19 pandemic prior to funding.
<a href="https://nexus.od.nih.gov/all/2022/01/11/extending-existing-guidance-for-preparing-applications-during-covid-19/">
https://nexus.od.nih.gov/all/2022/01/11/extending-existing-guidance-for-preparing-applications-during-covid-19/</a><strong><span style="font-family:"Calibri",sans-serif;font-weight:normal"><o:p></o:p></span></strong></p>
<div style="mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.5pt;padding:0in 0in 1.0pt 0in">
<p class="MsoNormal" style="border:none;padding:0in"><strong><span style="font-family:"Calibri",sans-serif;font-weight:normal"><o:p> </o:p></span></strong></p>
</div>
<p class="MsoNormal"><strong><span style="font-family:"Calibri",sans-serif;font-weight:normal"><o:p> </o:p></span></strong></p>
<h1 style="mso-margin-top-alt:0in;margin-right:0in;margin-bottom:11.25pt;margin-left:0in">
<strong><u><span style="font-size:12.0pt;font-family:"Calibri",sans-serif;color:#20558A">Reminder of NIH Closeout Policies</span></u></strong><u><span style="font-size:12.0pt;font-family:"Calibri",sans-serif;color:#20558A"><o:p></o:p></span></u></h1>
<p class="MsoNormal" style="background:white"><span style="color:#707070">By <a href="https://nexus.od.nih.gov/all/author/nih-staff/"><b><span style="color:#707070;text-decoration:none">NIH Staff</span></b></a></span><span style="color:#707070;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p style="background:white"><span style="color:black">Is your NIH grant coming to an end soon? Here’s a refresher on reporting deadlines, timeframes for drawing funds from the Payment Management System (PMS), and the process for amending a Federal Financial
Reports (FFR).<o:p></o:p></span></p>
<p style="background:white;box-sizing: border-box;margin:1rem;font-variant-ligatures: normal;font-variant-caps: normal;orphans: 2;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;word-spacing:0px">
<span style="color:black">Recipients must submit a final FFR, Final Research Performance Progress Report (RPPR), and Final Invention Statement and Certification within 120 calendar days of the end of the period of performance (<a href="https://grants.nih.gov/grants/policy/nihgps/HTML5/section_8/8.6_closeout.htm"><b><span style="color:#1462E0;text-decoration:none">see
NIHGPS Section 8.6</span></b></a>). In the event that additional time is needed to fulfill the closeout requirements (e.g. prepare, revise, or amend financial reports), a no-cost extension should be requested.<o:p></o:p></span></p>
<p style="background:white;box-sizing: border-box;margin:1rem;font-variant-ligatures: normal;font-variant-caps: normal;orphans: 2;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;word-spacing:0px">
<span style="color:black">Recipients may request payments from PMS up to 120 days past the period of performance end date, to liquidate obligations incurred during the period of performance. Per the NIH Grants Policy Statement, a term and condition of every
NIH award, recipients must submit timely, accurate final grant expenditure reports, and reconcile cash transaction reports submitted to the PMS with expenditure reports submitted to NIH.<o:p></o:p></span></p>
<p style="background:white;box-sizing: border-box;margin:1rem;font-variant-ligatures: normal;font-variant-caps: normal;orphans: 2;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;word-spacing:0px">
<span style="color:black">In rare cases, a recipient may need to revise or amend previously submitted expenditures more than 120 days past the period of performance end date in order to revise a previously submitted FFR. In these cases, the AOR must notify
the IC Grants Management Specialist listed in the NoA for additional guidance (<a href="https://grants.nih.gov/grants/policy/nihgps/HTML5/section_8/8.4.1_reporting.htm#Revised"><b><span style="color:#1462E0;text-decoration:none">see NIHGPS Section 8.4.1.5.3</span></b></a>).<o:p></o:p></span></p>
<div style="mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.5pt;padding:0in 0in 1.0pt 0in;background:white">
<p style="background:white;border:none;padding:0in;box-sizing: border-box;margin:1rem;font-variant-ligatures: normal;font-variant-caps: normal;orphans: 2;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;word-spacing:0px">
<span style="color:black">For more details, see the full <a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-102.html"><b><span style="color:#1462E0;text-decoration:none">Guide Notice</span></b></a>.<o:p></o:p></span></p>
<p style="background:white;border:none;padding:0in"><span style="font-size:12.0pt;font-family:"Nunito Sans";color:black"><o:p> </o:p></span></p>
</div>
<p style="background:white"><b><u><span style="font-size:12.0pt;color:#20558A">NSF Disclosures Relating to the Biosketch and Current and Pending Support<o:p></o:p></span></u></b></p>
<p class="xmsonormal">An important message from NSF:<o:p></o:p></p>
<p class="xmsonormal"> <o:p></o:p></p>
<p class="xmsonormal">>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> <o:p></o:p></p>
<p class="xmsonormal"> <o:p></o:p></p>
<p class="xmsonormal">Dear Colleagues:<o:p></o:p></p>
<p class="xmsonormal"> <o:p></o:p></p>
<p class="xmsonormal">NSF has issued an updated version of the table entitled <i>
<a href="https://www.nsf.gov/bfa/dias/policy/disclosures_table.jsp">NSF Pre-award and Post-award Disclosures Relating to the Biographical Sketch and Current and Pending Support</a></i>. The updated table dated January 10, 2022, includes information regarding
start-up packages provided by proposing organizations as well as outside organizations. Any questions regarding the contents of the table should be directed to the Policy Office at
<a href="mailto:policy@nsf.gov">policy@nsf.gov</a>. <o:p></o:p></p>
<p class="xmsonormal"> <o:p></o:p></p>
<p class="xmsonormal">Regards,<o:p></o:p></p>
<p class="xmsonormal"> <o:p></o:p></p>
<p class="xmsonormal">Jean Feldman<o:p></o:p></p>
<p class="xmsonormal">Head, Policy Office<o:p></o:p></p>
<p class="xmsonormal">Division of Institution and Award Support<o:p></o:p></p>
<p class="xmsonormal">Office of Budget, Finance & Award Management<o:p></o:p></p>
<p class="xmsonormal"><o:p> </o:p></p>
<p class="xmsonormal" style="margin-left:.75in"><span style="color:#20558A">* * *<o:p></o:p></span></p>
<p class="xmsonormal" style="margin-left:.75in"><span style="color:#20558A"><o:p> </o:p></span></p>
<p class="xmsonormal"><strong><i><span style="font-size:12.0pt;font-family:"Calibri",sans-serif;color:#20558A;background:white">Note: On January 10, 2022, NSF also issued <a href="https://www.nsf.gov/bfa/dias/policy/cps_faqs/currentandpendingfaqs_jan2022.pdf"><span style="color:#20558A;font-weight:normal">Current
and pending support FAQs</span></a></span></i></strong><span style="font-size:12.0pt;color:#20558A"><o:p></o:p></span></p>
<div style="mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.5pt;padding:0in 0in 1.0pt 0in">
<p class="MsoNormal" style="border:none;padding:0in"><o:p> </o:p></p>
</div>
<p class="MsoNormal"><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="Picture_x0020_1" o:spid="_x0000_s1027" type="#_x0000_t75" style='position:absolute;margin-left:-16.5pt;margin-top:-421.25pt;width:129.6pt;height:129.6pt;z-index:251658240;visibility:visible;mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;mso-height-relative:margin'>
<v:imagedata src="cid:image001.jpg@01D80852.6C06B8F0" o:title="" />
<w:wrap type="square"/>
</v:shape><![endif]--><![if !vml]><img width="173" height="173" style="width:1.8in;height:1.8in" src="cid:image003.jpg@01D80857.95A9A690" align="left" hspace="12" v:shapes="Picture_x0020_1"><![endif]><o:p></o:p></p>
<p class="MsoNormal" align="center" style="text-align:center"><i><u><span style="font-size:18.5pt;font-family:"Helvetica",sans-serif;color:#20558A;background:white">REMINDER:<o:p></o:p></span></u></i></p>
<p class="MsoNormal" align="center" style="text-align:center"><i><u><span style="font-size:18.5pt;font-family:"Helvetica",sans-serif;color:#20558A;background:white"><o:p><span style="text-decoration:none"> </span></o:p></span></u></i></p>
<p class="MsoNormal" align="center" style="text-align:center"><span style="font-size:18.5pt;font-family:"Helvetica",sans-serif;color:#20558A;background:white">Upcoming Changes to the NIH Biographical Sketch and the Other Support Format Page
<o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="text-align:center"><span style="font-size:18.5pt;font-family:"Helvetica",sans-serif;color:#20558A;background:white">Required for Applications, Just-in-Time Requests, and Research Performance Progress Reports (RPPRs) <o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="text-align:center"><span style="font-size:18.5pt;font-family:"Helvetica",sans-serif;color:#20558A;background:white">Due on or after January 25, 2022</span><span style="color:#20558A"><o:p></o:p></span></p>
<p class="MsoNormal"><s><o:p><span style="text-decoration:none"> </span></o:p></s></p>
<p class="MsoNormal">The National Institute of Health (NIH) issued Notice <a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-073.html">NOT-OD-21-073</a>,
<i>Upcoming Changes to the NIH Biographical Sketch and Other Support</i>, and subsequently issued Notice <a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-110.html">NOT-OD-21-110</a> which delayed the required use of the new Biographical Sketch
and Other Support format pages until January 25, 2022.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">All current and future investigators supported by NIH awards are strongly encouraged to review these notices, along with the related format instructions and frequently asked questions, to familiarize themselves with the new requirements. <o:p></o:p></p>
<p class="MsoNormal"><b>NIH is enforcing these changes on all applications, Just-in-Time requests, and Research Performance Progress Reports (RPPRs) as of January 25, 2022</b>.
<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Submissions that do not conform to the new requirements may cause NIH to withdraw the submission from consideration (i.e., return without review) due to noncompliance (see <a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-073.html" target="_blank" title="Original URL: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-073.html. Click or tap if you trust this link.">NOT-OD-21-073</a>).<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<div align="center">
<table class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" width="92%" style="width:92.96%;border:solid windowtext 1.0pt">
<tbody>
<tr style="height:13.5pt">
<td width="100%" valign="top" style="width:100.0%;border:solid windowtext 1.0pt;padding:7.5pt 0in 0in 0in;height:13.5pt">
<p class="MsoNormal" style="line-height:115%">Twice this month, the Office of Research of Economic Development will be presenting “<b><span style="color:#20558A">Changes to the NIH Biographical Sketch & Other Support</span></b><span style="color:#39394D">”
– which is an </span>informational workshop for researchers.<o:p></o:p></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoListParagraphCxSpFirst" style="margin-left:0in;mso-add-space:auto;line-height:115%;mso-list:l2 level1 lfo1">
The first workshop will be held <b><span style="color:#20558A">Friday, January 14, 2022</span></b>, from
<b><span style="color:#20558A">Noon – 1PM</span></b>.<o:p></o:p></li><li class="MsoListParagraphCxSpLast" style="margin-left:0in;mso-add-space:auto;line-height:115%;mso-list:l2 level1 lfo1">
The second workshop will be held on <b><span style="color:#20558A">Thursday, January 20, 2022</span></b>, from
<b><span style="color:#20558A">Noon – 1PM</span></b>.<o:p></o:p></li></ul>
<p class="MsoNormal"><b>Each workshop will contain the <u>same content</u></b>, so please attend the one which is most convenient. The ZOOM link to each workshop is available
<a href="https://research.ucr.edu/spa/NIH-Bio-Other-Support#workshops">https://research.ucr.edu/spa/NIH-Bio-Other-Support#workshops</a>.
<o:p></o:p></p>
<p class="MsoNormal">(A power point presentation will subsequently be posted for those who are unable to attend and/or for later reference.)<o:p></o:p></p>
<p class="MsoNormal" style="line-height:115%"><span style="color:#39394D"><o:p> </o:p></span></p>
</td>
</tr>
</tbody>
</table>
</div>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><u>Below is an overview of some of the forthcoming NIH requirements</u>:<o:p></o:p></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b>Biosketch -
</b>Use of new NIH Biosketch templates will be required, with the following changes to the requirements:<o:p></o:p></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto">Two options for creating a NIH Biosketch: <a name="_Hlk88554992"></a><a name="_Hlk88555041"></a><a href="https://www.ncbi.nlm.nih.gov/sciencv/">SciENcv</a> (recommended by UCR)
or Word template. <a href="https://grants.nih.gov/grants/forms/biosketch.htm">Instructions, FAQ, samples and the current Word templates are available here</a>.<o:p></o:p></p>
<ul type="disc">
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:115%;mso-list:l4 level1 lfo2">
Section A: Applicants may choose to include details on ongoing and completed research projects from the past three years that they want to draw attention to. Formatting samples provided in <a href="http://grants.nih.gov/grants/forms/non-fellowship-biosketch-sample-2021.docx">NIH’s
sample biosketch</a>.<o:p></o:p></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:115%;mso-list:l4 level1 lfo2">
Section B: Section B has been renamed ‘<a name="_Hlk88555459">Positions, <span style="color:red">
Scientific Appointments</span>, and Honors’</a>. List in <b><i>reverse chronological</i></b> order all <b><i>current</i></b> positions and scientific appointments both domestic and foreign, including affiliations with foreign entities or governments.<o:p></o:p></li></ul>
<ul type="disc">
<ol start="1" type="1">
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:115%;mso-list:l4 level2 lfo3">
For foreign appointments, supporting documentation will need to be provided at the Just-In-Time (JIT) phase as detailed under Other Support.<o:p></o:p></li></ol>
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:115%;mso-list:l4 level1 lfo3">
Section D: “Research Support” removed for non-Fellowship Biosketches. Included on Fellowship Biosketches as “Scholastic Performance”.<o:p></o:p></li></ul>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b>Other Support -
</b> Use of new Other Support templates will be required, with the following changes to the requirements:<o:p></o:p></p>
<ul type="disc">
<li class="MsoListParagraph" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;margin-left:0in;mso-add-space:auto;mso-list:l5 level1 lfo4">
SciENcv is not yet an available option for creating the Other Support page (although it is anticipated to be forthcoming in spring 2022 from NIH). Until then, the
<b><span style="color:#20558A">NIH Word template must be utilized to prepare Other Support information</span></b>.
<a name="_Hlk88555076"> Such Word template contains a certification as to the accuracy of the information disclosed and, therefore, NIH requires that the template</a> be converted to a PDF, and electronically signed by the researcher. Typed names and wet signatures
are not accepted. (This is an interim process while NIH moves to the use of SciENcv templates for Other Support.)
<o:p></o:p></li></ul>
<ul type="disc">
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l3 level1 lfo5">
New format with sections to disclose all sources of other support and related information.<o:p></o:p></li><ul type="circle">
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l3 level2 lfo5">
NIH has emphasized that investigators must disclose all sources of Other Support (Total costs (Direct and Indirect) for the entire project period) and related information, including outside activities (e.g. consulting that involves research, visiting professorships)
if conducting research, in-kind support, and gifts if donor expects anything in return (e.g. time, services, research).<o:p></o:p></li><ul type="square">
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:115%;mso-list:l3 level3 lfo5">
<b>In-Kind Contributions Section: </b>Separated from funded projects. Provide Active and Pending In-Kind contributions for all senior/key personnel. Enter in-kind entries grouped together based on the "Status of Support" and in order of Active and Pending Support
from top to bottom. If there is no associated effort level, zero effort can be listed but an estimated dollar value must be listed; <b>effort and dollar value cannot both be zero.</b><o:p></o:p></li></ul>
</ul>
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l3 level1 lfo5">
Investigators must submit supporting documentation, including contracts, grants, or any other agreement, for foreign appointments/ employment in connection with foreign activities and resources reported in Other Support
<o:p></o:p></li><ul type="circle">
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l3 level2 lfo5">
Effective January 25, 2022, this will be mandatory for all senior/key personnel.<o:p></o:p></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l3 level2 lfo5">
If the contracts, grants or other agreements are not in English, recipients must provide translated copies.
<o:p></o:p></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l3 level2 lfo5">
This supporting documentation must be provided as part of the Other Support pdf following the Other Support Format page.<o:p></o:p></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l3 level2 lfo5">
NIH has reserved the right to request copies of any contracts, grants or any other agreements that are related to faculty research endeavors reported in Other Support. (If NIH requests additional documentation, please contact your department’s designated
<a href="https://redit.ucr.edu/OrApps/RED/Staff.aspx?t=3">Contract and Grant Officer</a> in Sponsored Programs Administration (SPA) before providing the requested documents.)<o:p></o:p></li></ul>
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l3 level1 lfo5">
PD/PI or senior/key personnel must electronically sign the following certification on each Other Support page:<o:p></o:p></li><ul type="circle">
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l3 level2 lfo5">
I, PD/PI or other senior/key personnel, <b>certify that the statements herein are true</b>, complete and accurate to the best of my knowledge, and accept the obligation to comply with Public Health Services terms and conditions if a grant is awarded as a result
of this application. I am aware that any false, fictitious, or fraudulent statements or claims may subject me to criminal, civil, or administrative penalties.<o:p></o:p></li></ul>
</ul>
<ul type="disc">
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:115%;mso-list:l0 level1 lfo6">
<b><span style="color:#20558A">Immediate Notification of Undisclosed Other Support</span></b><b>:</b> If you discover that other support has not been disclosed to NIH, please alert your
<a href="https://redit.ucr.edu/OrApps/RED/Staff.aspx?t=3">Contract and Grant Officer</a> immediately so that NIH may promptly be updated.<o:p></o:p></li></ul>
<h3 style="margin-top:0in;background:white;vertical-align:baseline"><strong><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:#111111;border:none windowtext 1.0pt;padding:0in">URLs -
</span></strong><strong><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:#111111;border:none windowtext 1.0pt;padding:0in;font-weight:normal">Please be advised tha</span></strong><span style="font-size:11.0pt;font-family:"Calibri",sans-serif">t
</span><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:black">Hyperlinks and URLs are <strong><span style="font-family:"Calibri",sans-serif;border:none windowtext 1.0pt;padding:0in">not</span></strong> allowed outside of the References
Cited and Biosketch documents. Biosketches only allow a URL to a full list of the individual’s published work and such URL must be a government (.gov) website.</span><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;color:windowtext"><o:p></o:p></span></h3>
<div style="border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt">
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto">Due to the significant changes being implemented by the NIH, UCR’s Sponsored Programs Administration has developed a helpful webpage on this topic with the pertinent information,
instructions, and forms. <span style="background:yellow;mso-highlight:yellow">Please visit
<a href="https://research.ucr.edu/spa/NIH-Bio-Other-Support">https://research.ucr.edu/spa/NIH-Bio-Other-Support</a>.</span><b><span style="color:#20558A"><o:p></o:p></span></b></p>
</div>
<div align="center">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%;border-collapse:collapse">
<tbody>
<tr>
<td style="padding:0in 0in 0in 0in">
<p class="MsoNormal">Should you have further questions, please reach out to your department’s designated
<a href="https://redit.ucr.edu/OrApps/RED/Staff.aspx?t=3">Contract and Grant Officer</a>.<span style="mso-fareast-language:EN-US"><o:p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
</div>
<div style="border:none;border-bottom:solid windowtext 1.5pt;padding:0in 0in 1.0pt 0in">
<p class="MsoNormal"><b><o:p> </o:p></b></p>
<p class="MsoNormal"><b><o:p> </o:p></b></p>
</div>
<p class="MsoNormal"><b><o:p> </o:p></b></p>
<h2><b><u><span style="font-size:12.0pt;font-family:"Calibri",sans-serif;color:#20558A">NIH – Expanding Requirement for eRA Commons IDs to All Senior/Key Personnel</span></u></b><b><span style="font-size:18.0pt;font-family:"Calibri",sans-serif;color:black"><o:p></o:p></span></b></h2>
<p class="MsoNormal"><b><o:p> </o:p></b></p>
<p class="MsoNormal">For <b>applications with due dates on or after January 25, 2022</b>, NIH, AHRQ, FDA, and ORD/VA will
<b>require all individuals listed on the R&R Senior/Key Person Profile (Expanded) Form to have an eRA Commons username</b> (Commons ID).
<o:p></o:p></p>
<p class="MsoNormal">Extension of the existing eRA Commons ID requirement to include all senior/key personnel will facilitate better data collection for individuals contributing to federally funded research as well as assist in disambiguating data on applications
and facilitating the identification of conflicts of interest in peer review.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="mso-list:l6 level1 lfo7">This new requirement applies to all Senior/Key Personnel and Other Significant Contributors proposed in NIH applications. (This requirement already existed for PIs and co-PIs.)<o:p></o:p></li><li class="MsoNormal" style="mso-list:l6 level1 lfo7">UCR will only create Commons IDs for UCR personnel. Non-UCR personnel can set up Commons IDs with their employing entity or, if unrelated to an entity, non-UCR personnel must complete all the required registrations
as though they are an organization following <a href="https://grants.nih.gov/grants/ElectronicReceipt/UnaffiliatedUserRegistration.pdf">
the unaffiliated guidance detailed here</a>. NIH recommends starting the registration process for unaffiliated individuals at least six weeks prior to a deadline to allow plenty of time to address unforeseen issues along the way.<o:p></o:p></li><li class="MsoNormal" style="mso-list:l6 level1 lfo7">Missing Commons ID for all Senior/Key Personnel will cause a Warning; however, NIH is targeting to have a missing Commons ID result in an
<b>ERROR</b> that must be corrected before the application can be submitted to the agency. The official targeting date has not yet been announced.<o:p></o:p></li></ul>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">For further information, please see NIH Notice <a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-109.html">
NOT-OD-21-109</a>.<o:p></o:p></p>
<div style="border:none;border-bottom:solid windowtext 1.5pt;padding:0in 0in 1.0pt 0in">
<p class="MsoNormal"><b><o:p> </o:p></b></p>
</div>
<p><b><u><span style="font-size:12.0pt;color:#20558A">How To Subscribe to this Research List-Serv<o:p></o:p></span></u></b></p>
<div style="mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.5pt;padding:0in 0in 1.0pt 0in">
<p style="border:none;padding:0in">Do you know of someone in your department who is not currently registered to receive newsletters (such as this one) from the Research list-serv, but would like to be? If so, please forward their name and email to
<a href="mailto:cynthia.wells@ucr.edu">cynthia.wells@ucr.edu</a>.<o:p></o:p></p>
<p style="border:none;padding:0in"><u><o:p><span style="text-decoration:none"> </span></o:p></u></p>
</div>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%;border-collapse:collapse">
<tbody>
<tr>
<td style="padding:0in 0in 0in 0in">
<p class="MsoNormal" align="center" style="text-align:center"><img border="0" width="82" height="82" style="width:.8583in;height:.8583in" id="_x0000_i1071" src="https://content.govdelivery.com/attachments/fancy_images/USNIHOER/2021/03/4305822/3475336/icon-calendar_crop.png" alt="icon_Calendar"><o:p></o:p></p>
</td>
</tr>
</tbody>
</table>
<h1 align="center" style="margin-top:0in;text-align:center"><b><span style="font-size:16.5pt;font-family:"Arial",sans-serif;color:#20558A"> </span></b><span style="font-size:16.5pt;font-family:"Arial",sans-serif;color:#20558A"><o:p></o:p></span></h1>
<p class="MsoNormal" align="center" style="text-align:center"><strong><span style="font-size:16.5pt;font-family:"Arial",sans-serif;color:#20558A;font-weight:normal">Calendar</span></strong><span style="mso-fareast-language:EN-US"><o:p></o:p></span></p>
<div style="border:none;border-bottom:solid windowtext 1.5pt;padding:0in 0in 1.0pt 0in">
<p class="MsoNormal" align="center" style="text-align:center"><span style="mso-fareast-language:EN-US"><o:p> </o:p></span></p>
<div align="center">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%;border-collapse:collapse">
<tbody>
<tr style="height:9.55in">
<td width="100%" valign="top" style="width:100.0%;padding:0in 0in 0in 0in;height:9.55in">
<p><b><span style="color:#20558A">1/14/2022 and 1/20/2022 – Faculty workshop: <i>
Changes to the NIH Biographical Sketch & Other Support</i></span></b> <a href="https://research.ucr.edu/spa/NIH-Bio-Other-Support#workshops">
https://research.ucr.edu/spa/NIH-Bio-Other-Support#workshops</a><o:p></o:p></p>
<p><!--[if gte vml 1]><v:shape id="Picture_x0020_2" o:spid="_x0000_s1026" type="#_x0000_t75" alt="Events for January 17, 2022 – September 6 – Collegedale Public Library" style='position:absolute;margin-left:-9pt;margin-top:-28.2pt;width:152.4pt;height:166.75pt;z-index:251659264;visibility:visible;mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;mso-height-relative:margin'>
<v:imagedata src="cid:image004.jpg@01D80857.36A30560" o:title="Events for January 17, 2022 – September 6 – Collegedale Public Library" />
<w:wrap type="through"/>
</v:shape><![endif]--><![if !vml]><img width="203" height="222" style="width:2.1166in;height:2.3166in" src="cid:image006.jpg@01D80857.95A9A690" align="left" hspace="12" alt="Events for January 17, 2022 – September 6 – Collegedale Public Library" v:shapes="Picture_x0020_2"><![endif]><b><span style="color:#20558A">
<o:p></o:p></span></b></p>
<p><b><span style="color:#20558A">UCR will be closed on Monday, January 17<sup>th</sup> in observation of the Martin Luther King, Jr. holiday<o:p></o:p></span></b></p>
<p><b><span style="color:#20558A"><o:p> </o:p></span></b></p>
<p><b><span style="color:#20558A"><o:p> </o:p></span></b></p>
<p><b><span style="color:#20558A"><o:p> </o:p></span></b></p>
<p><o:p> </o:p></p>
</td>
</tr>
</tbody>
</table>
</div>
<p class="MsoNormal"><b><o:p> </o:p></b></p>
</div>
</div>
</body>
</html>